Park Place Capital Corp Sells 180 Shares of Danaher Co. (NYSE:DHR)

Park Place Capital Corp lowered its holdings in Danaher Co. (NYSE:DHR) by 12.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,280 shares of the conglomerate’s stock after selling 180 shares during the period. Park Place Capital Corp’s holdings in Danaher were worth $320,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Cape Investment Advisory Inc. acquired a new position in Danaher in the 4th quarter valued at $25,000. Tsfg LLC increased its holdings in Danaher by 733.3% in the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares during the period. BKM Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter worth approximately $27,000. Wetzel Investment Advisors Inc. bought a new position in Danaher in the fourth quarter valued at approximately $29,000. Finally, Rakuten Securities Inc. bought a new stake in Danaher during the fourth quarter worth $36,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, CEO Rainer Blair sold 9,005 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the sale, the chief executive officer now directly owns 106,990 shares in the company, valued at $28,352,350. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, CFO Matthew Mcgrew sold 46,377 shares of Danaher stock in a transaction on Friday, May 10th. The shares were sold at an average price of $253.05, for a total transaction of $11,735,699.85. Following the completion of the sale, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at approximately $7,441,441.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Rainer Blair sold 9,005 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the completion of the sale, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The disclosure for this sale can be found here. Insiders sold 148,783 shares of company stock valued at $37,536,717 over the last three months. Company insiders own 10.90% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Robert W. Baird lifted their price target on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. TD Cowen lifted their price target on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. Jefferies Financial Group started coverage on shares of Danaher in a report on Monday, June 3rd. They set a “buy” rating and a $295.00 price target for the company. Finally, Citigroup raised their price objective on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $269.29.

Danaher Trading Down 2.1 %

DHR opened at $244.51 on Tuesday. The company has a market cap of $181.11 billion, a P/E ratio of 41.44, a price-to-earnings-growth ratio of 3.82 and a beta of 0.84. The company has a fifty day moving average price of $255.96 and a two-hundred day moving average price of $246.75. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $269.11.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating the consensus estimate of $1.72 by $0.20. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.36 earnings per share. Analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s payout ratio is 18.31%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.